Skip to content

Laboratory Outcome Predictors in Coronary Surgery

Markers of Tissue Perfusion as Predictors of Complicated Evolution in Patients With Left Ventricular Dysfunction Submitted to Coronary Artery Bypass Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01178866
Enrollment
87
Registered
2010-08-10
Start date
2006-01-31
Completion date
2008-03-31
Last updated
2010-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Surgery, Left Ventricular Dysfunction, Tissue Hypoperfusion

Keywords

thoracic surgery, myocardial revascularization, left ventricular dysfunction, tissue perfusion, prognosis

Brief summary

Evaluate less employed markers of tissue hypoperfusion as venoarterial carbon dioxide partial pressure difference (ΔPCO2) and estimated respiratory quotient (eRQ) combined to other classically studied markers as predictive factors of complicated clinical course after cardiac surgery in patients with left ventricular dysfunction.

Detailed description

Patients with left ventricular dysfunction are more susceptible to tissue hypoperfusion and presents more frequently both low cardiac output syndrome and systemic inflammatory response, what results in prolonged stay in intensive care unit (ICU), and higher mortality rates when compared to patients with normal ventricular function. The early prediction of prolonged ICU stay through the detection of tissue hypoperfusion may improve the management of care and decrease morbidity of this particular group of patients. However, classic markers of tissue hypoxia as central venous saturation, base excess, lactate may not be predictors of outcome in cardiac surgery patients with left ventricular dysfunction. The question addressed in this study is if less employed markers of tissue hypoperfusion as as venoarterial carbon dioxide partial pressure difference (ΔPCO2) and estimated respiratory quotient (eRQ) have predictive value of prolonged ICU stay in patients with left ventricular dysfunction submitted to coronary artery bypass surgery.

Interventions

None listed

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adults * left ventricular dysfunction (ejection fraction \< 50%) * patients undergoing coronary artery bypass surgery requiring the use of Cardiopulmonary Bypass (CPB)

Exclusion criteria

* renal failure (creatinine clearance lower than 40 ml/min/m2), * hepatic dysfunction * endocrinologic disorders * pulmonary disease * uncontrolled diabetes mellitus * a history of fever or infection within the week before surgery * previous anemia (hemoglobin ≤ 10.0 g/dL)

Design outcomes

Primary

MeasureTime frameDescription
Complicated clinical course after coronary artery bypass surgerywithin the first 30 days after surgeryComplicated clinical course defined as death within the first 30 days after surgery or ICU stay more than 4 days.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026